Scientists at the National Institute of Neurological Disorders and Stroke (NINDS) studying neurobehavior are seeking patients with cortical basal ganglionic degeneration for cognitive neuroscience studies.
Eligible patients should be mild to moderately affected, between the ages of 18 and 70, and have no other current significant disease. Those enrolled in the study will undergo neuropsychological testing and brain imaging studies. The studies will be conducted at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD. All study-related expenses will be paid by the NIH.
For more information, physicians should contact Dr. Jordan Grafman, Chief, Cognitive Neuroscience Section, NINDS, Building 10, Room 5C205, 10 Center Drive MSC 1440; Bethesda, MD 20892-1440; telephone: (301) 496-0220; fax: (301) 480-2909; email: email@example.com.